LazamSVanoverscheldeJLTribouilloyC, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation2017; 135: 410–422.
2.
GillinovAMWierupPNBlackstoneEH, et al. Is repair preferable to replacement for ischemic mitral regurgitation?J Thorac Cardiovasc Surg2001; 122: 1125–1141.
3.
BachDSBollingSF. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol1996; 78: 966–969.
4.
GoldsteinDMoskowitzAJGelijnsAC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med2016; 374: 344–353.
5.
NappiFLusiniMSpadaccioC, et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol2016; 67: 2334–2346.
6.
LevineRAHagégeAAJudgeDP, et al. Mitral valve disease—morphology and mechanisms. Nat Rev Cardiol2015; 12: 689–710.
7.
GolbaKMokrzyckiKDrozdzJ, et al. Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol2013; 112: 1812–1818.
8.
GammieJSQuinnRWStraussER, et al. Initial clinical experience with mitral valve translocation for secondary mitral regurgitation. Ann Thorac Surg2021; 112: 1946–1953.
9.
PasrijaCQuinnRGhoreishiM, et al. A novel quantitative ex vivo model of functional mitral regurgitation. Innovations2020; 15: 329–337.
10.
QuinnRWPasrijaCBernsteinDA, et al. Mitral valve translocation: optimization of patch geometry in an ex vivo model of secondary mitral regurgitation. J Cardiovasc Transl Res2021; 15: 666–675.
11.
PasrijaCQuinnRStraussE, et al. Translocation of the mitral valve in an acute large animal model. J Cardiovasc Transl Res2022; 15: 1100–1107.
12.
PasrijaCQuinnRWBernsteinD, et al. Mitral valve translocation: a novel operation for the treatment of secondary mitral regurgitation. Ann Thorac Surg2021; 112: 1954–1961.
13.
GogoladzeGDellisSLDonninoR, et al. Analysis of the mitral coaptation zone in normal and functional regurgitant valves. Ann Thorac Surg2010; 89: 1158–1161.
14.
VargheseRItagakiSAnyanwuAC, et al. Predicting systolic anterior motion after mitral valve reconstruction: using intraoperative transoesophageal echocardiography to identify those at greatest risk. Eur J Cardiothorac Surg2014; 45: 132–138.
15.
StraussERQuinnRWPasrijaC, et al. Intraoperative echocardiographic assessment of mitral valve translocation. Eur J Cardiothorac Surg2022; 62: ezac133.
16.
BraunJBaxJJVersteeghMIM, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg2005; 27: 847–853.
17.
GreenhouseDGDellisSLSchwartzCF, et al. Regional changes in coaptation geometry after reduction annuloplasty for functional mitral regurgitation. Ann Thorac Surg2012; 93: 1876–1880.
18.
ZhuFOtsujiYYotsumotoG, et al. Mechanism of persistent ischemic mitral regurgitation after annuloplasty: importance of augmented posterior mitral leaflet tethering. Circulation2005; 112(9 Suppl): I396–I401.
19.
BraunJvan de VeireNRKlautzRJM, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg2008; 85: 430–437.
20.
SatoHCavalcanteJLBaeR, et al. Coaptation reserve predicts optimal reduction in mitral regurgitation and long-term survival with transcatheter edge-to-edge repair. Circ Cardiovasc Interv2022; 15: E011562.
